These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 8069869

  • 1. Expression and localization of urokinase-type plasminogen activator receptor in human gliomas.
    Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, Nicolson GL, Rao JS.
    Cancer Res; 1994 Sep 15; 54(18):5016-20. PubMed ID: 8069869
    [Abstract] [Full Text] [Related]

  • 2. Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo.
    Yamamoto M, Sawaya R, Mohanam S, Loskutoff DJ, Bruner JM, Rao VH, Oka K, Tomonaga M, Nicolson GL, Rao JS.
    Cancer Res; 1994 Jul 01; 54(13):3329-32. PubMed ID: 8012944
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression and significance of urokinase type plasminogen activator gene in human brain gliomas.
    Zhang X, Fei Z, Bu X, Zhen H, Zhang Z, Gu J, Chen Y.
    J Surg Oncol; 2000 Jun 01; 74(2):90-4. PubMed ID: 10914816
    [Abstract] [Full Text] [Related]

  • 5. Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas.
    Yamamoto M, Ikeda K, Ohshima K, Tsugu H, Kimura H, Tomonaga M.
    Cancer Res; 1997 Jul 01; 57(13):2799-805. PubMed ID: 9205092
    [Abstract] [Full Text] [Related]

  • 6. Expression and localisation of urokinase-type plasminogen activator gene in gliomas.
    Zhang X, Bu XY, Zhen HN, Fei Z, Zhang JN, Fu LA.
    J Clin Neurosci; 2000 Mar 01; 7(2):116-9. PubMed ID: 10844794
    [Abstract] [Full Text] [Related]

  • 7. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody.
    Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, Rao JS.
    Cancer Res; 1993 Sep 15; 53(18):4143-7. PubMed ID: 8395977
    [Abstract] [Full Text] [Related]

  • 8. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
    Rao CN, Lakka SS, Kin Y, Konduri SD, Fuller GN, Mohanam S, Rao JS.
    Clin Cancer Res; 2001 Mar 15; 7(3):570-6. PubMed ID: 11297250
    [Abstract] [Full Text] [Related]

  • 9. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS.
    Cancer Res; 1996 Jan 15; 56(2):384-92. PubMed ID: 8542596
    [Abstract] [Full Text] [Related]

  • 10. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.
    Mohanam S, Chintala SK, Go Y, Bhattacharya A, Venkaiah B, Boyd D, Gokaslan ZL, Sawaya R, Rao JS.
    Oncogene; 1997 Mar 20; 14(11):1351-9. PubMed ID: 9178895
    [Abstract] [Full Text] [Related]

  • 11. Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.
    Bhattacharya A, Lakka SS, Mohanam S, Boyd D, Rao JS.
    Clin Cancer Res; 2001 Feb 20; 7(2):267-76. PubMed ID: 11234878
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y, Hayashi Y, Imai Y, Itoh H.
    Kobe J Med Sci; 1998 Feb 20; 44(1):31-43. PubMed ID: 9846056
    [Abstract] [Full Text] [Related]

  • 15. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V, Schroeder J, Denkert C, Kristiansen G, Schnorr D, Loening SA, Jung K, Staack A.
    Oncol Rep; 2004 Oct 20; 12(4):909-13. PubMed ID: 15375521
    [Abstract] [Full Text] [Related]

  • 16. Plasminogen activators and inhibitors in gliomas: an immunohistochemical study.
    Caccamo DV, Keohane ME, McKeever PE.
    Mod Pathol; 1994 Jan 20; 7(1):99-104. PubMed ID: 8159659
    [Abstract] [Full Text] [Related]

  • 17. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S, Chandrasekar N, Yanamandra N, Khawar S, Mirza F, Dinh DH, Olivero WC, Rao JS.
    Oncogene; 2002 Nov 07; 21(51):7824-30. PubMed ID: 12420219
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth.
    Mohan PM, Chintala SK, Mohanam S, Gladson CL, Kim ES, Gokaslan ZL, Lakka SS, Roth JA, Fang B, Sawaya R, Kyritsis AP, Rao JS.
    Cancer Res; 1999 Jul 15; 59(14):3369-73. PubMed ID: 10416596
    [Abstract] [Full Text] [Related]

  • 20. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 15; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.